Ligand Pharmaceuticals Incorporated Stock Today
| LGND Stock | USD 71.00 1.11 1.59% |
Performance0 of 100
| Odds Of DistressLess than 3
|
Ligand Pharmaceuticals is trading at 71.00 as of the 25th of April 2024, a 1.59 percent increase since the beginning of the trading day. The stock's lowest day price was 71.0. Ligand Pharmaceuticals has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Ligand Pharmaceuticals Incorporated are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 18th of November 1992 | Category Healthcare | Classification Health Care |
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. The company was incorporated in 1987 and is based in San Diego, California. The company has 17.71 M outstanding shares of which 672.08 K shares are now shorted by private and institutional investors with about 3.1 trading days to cover. More on Ligand Pharmaceuticals Incorporated
Moving against Ligand Stock
| 0.42 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
Ligand Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ligand Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ligand Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and Executive Director | John Higgins | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, SP Small-Cap 600, NASDAQ Biotechnology, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Ligand Pharmaceuticals report their recommendations after researching Ligand Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Ligand Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Ligand Pharmaceuticals. The Ligand consensus assessment is calculated by taking the average forecast from all of the analysts covering Ligand Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Ligand Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Ligand Pharmaceuticals Incorporated is doing better financially then in previous quarter. It has a moderate odds of reporting better financial numbers in May. Financial strength of Ligand Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ligand Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Ligand Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ligand Pharmaceuticals' financial leverage. It provides some insight into what part of Ligand Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ligand Pharmaceuticals Incorporated (LGND) is traded on NASDAQ Exchange in USA. It is located in 555 Heritage Drive, Jupiter, FL, United States, 33458 and employs 58 people. Ligand Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ligand Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Ligand Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ligand Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 17.71 M outstanding shares of which 672.08 K shares are now shorted by private and institutional investors with about 3.1 trading days to cover.
Ligand Pharmaceuticals Incorporated currently holds about 147.94 M in cash with 49.58 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.76.
Check Ligand Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationLigand Pharmaceuticals Incorporated holds a total of 17.71 Million outstanding shares. The majority of Ligand Pharmaceuticals outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Ligand Pharmaceuticals Incorporated to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Ligand Pharmaceuticals. Please pay attention to any change in the institutional holdings of Ligand Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Ligand Ownership Details
Ligand Stock Price Odds Analysis
What are Ligand Pharmaceuticals' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Ligand Pharmaceuticals jumping above the current price in 90 days from now is about 84.71%. The Ligand Pharmaceuticals Incorporated probability density function shows the probability of Ligand Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.2475. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ligand Pharmaceuticals will likely underperform. Additionally, ligand Pharmaceuticals Incorporated has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Ligand Pharmaceuticals to move above the current price in 90 days from now is about 84.71 (This Ligand Pharmaceuticals Incorporated probability density function shows the probability of Ligand Stock to fall within a particular range of prices over 90 days) .
Ligand Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Ligand Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ligand Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ligand Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Rice Hall James & Associates, Llc | 2023-12-31 | 276 K | |
| Chicago Capital, Llc | 2023-12-31 | 231.5 K | |
| Cardinal Capital Management Llc | 2023-12-31 | 221.9 K | |
| Northern Trust Corp | 2023-12-31 | 219.8 K | |
| Amvescap Plc. | 2023-12-31 | 214.9 K | |
| Impax Asset Management Group Plc | 2023-12-31 | 205.2 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 199.2 K | |
| William Blair Investment Management, Llc | 2023-12-31 | 187.3 K | |
| Deutsche Bank Ag | 2023-12-31 | 185.9 K | |
| Blackrock Inc | 2023-12-31 | 3 M | |
| Vanguard Group Inc | 2023-12-31 | 1.9 M |
Ligand Pharmaceuticals Historical Income Statement
Ligand Pharmaceuticals Incorporated Income Statement is one of the three primary financial statements used for reporting Ligand's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Ligand Pharmaceuticals revenue and expense. Ligand Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Ligand Pharmaceuticals' Operating Income is projected to increase significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 16.4 M, whereas Total Revenue is forecasted to decline to about 101.8 M. View More FundamentalsLigand Stock Against Markets
Picking the right benchmark for Ligand Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Ligand Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Ligand Pharmaceuticals is critical whether you are bullish or bearish towards Ligand Pharmaceuticals Incorporated at a given time. Please also check how Ligand Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ligand Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Ligand Pharmaceuticals Corporate Directors
Ligand Pharmaceuticals corporate directors refer to members of a Ligand Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Ligand Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Ligand Pharmaceuticals' board members must vote for the resolution. The Ligand Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Jason Aryeh | Independent Director | Profile | |
| Nancy Gray | Director | Profile | |
| Todd Davis | Independent Director | Profile | |
| John LaMattina | Independent Director | Profile |
How to buy Ligand Stock?
Before investing in Ligand Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Ligand Pharmaceuticals. To buy Ligand Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Ligand Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Ligand Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Ligand Pharmaceuticals Incorporated stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Ligand Pharmaceuticals Incorporated stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Ligand Pharmaceuticals Incorporated, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Ligand Stock please use our How to Invest in Ligand Pharmaceuticals guide.
Already Invested in Ligand Pharmaceuticals Incorporated?
The danger of trading Ligand Pharmaceuticals Incorporated is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ligand Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ligand Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ligand Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Ligand Pharmaceuticals is a strong investment it is important to analyze Ligand Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ligand Pharmaceuticals' future performance. For an informed investment choice regarding Ligand Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Ligand Pharmaceuticals Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Ligand Stock analysis
When running Ligand Pharmaceuticals' price analysis, check to measure Ligand Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ligand Pharmaceuticals is operating at the current time. Most of Ligand Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ligand Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ligand Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ligand Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Ligand Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ligand Pharmaceuticals. If investors know Ligand will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ligand Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share 3.03 | Revenue Per Share 7.591 | Quarterly Revenue Growth (0.44) | Return On Assets 0.0079 |
The market value of Ligand Pharmaceuticals is measured differently than its book value, which is the value of Ligand that is recorded on the company's balance sheet. Investors also form their own opinion of Ligand Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ligand Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ligand Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ligand Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ligand Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ligand Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ligand Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.